Genetic variants of CYP19 (aromatase) and breast cancer risk

被引：0
|
作者：
V Nedelcheva Kristensen
N Harada
N Yoshimura
E Haraldsen
PE Lønning
B Erikstein
R Kåresen
T Kristensen
A-L Børresen-Dale
机构：
[1] Department of Genetics,Department of Oncology, Institute of Cancer Research
[2] The Norwegian Radium Hospital,Department of Biochemistry, School of Medicine
[3] Fujita Health University,Department of Oncology
[4] Haukeland Hospital,Department of Oncology
[5] University of Bergen,Department of Biochemistry
[6] Ulleval Hospital,undefined
[7] University of Oslo,undefined
来源：
Breast Cancer Research | / 2卷 / Suppl 1期
关键词：
Breast Cancer; Estrogen; Cancer Risk; Linkage Disequilibrium; Breast Cancer Patient;
D O I：
10.1186/bcr153
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Genetic variants of CYP19 (aromatase) and breast cancer risk
    Kristensen, VN
    Harada, N
    Yoshimura, N
    Haraldsen, E
    Lonning, P
    Erikstein, B
    Kåresen, R
    Kristensen, T
    Borresen-Dale, AL
    [J]. ONCOGENE, 2000, 19 (10) : 1329 - 1333
  • [2] Genetic variants of CYP19 (aromatase) and breast cancer risk
    Vessela Nedelcheva Kristensen
    Nobuhiro Harada
    Noriko Yoshimura
    Ellen Haraldsen
    P E Lønning
    Bjørn Erikstein
    Rolf Kåresen
    Tom Kristensen
    Anne-Lise Børresen-Dale
    [J]. Oncogene, 2000, 19 : 1329 - 1333
  • [3] Constitutional genetic variation at the human aromatase gene (Cyp19) and breast cancer risk
    Siegelmann-Danieli, N
    Buetow, KH
    [J]. BRITISH JOURNAL OF CANCER, 1999, 79 (3-4) : 456 - 463
  • [4] Constitutional genetic variation at the human aromatase gene (Cyp19) and breast cancer risk
    N Siegelmann-Danieli
    K H Buetow
    [J]. British Journal of Cancer, 1999, 79 : 456 - 463
  • [5] A CYP19 (aromatase) polymorphism is associated with increased premenopausal breast cancer risk
    Talbott, Kathryn E.
    Gammon, Marilie D.
    Kibriya, Muhammad G.
    Chen, Yu
    Teitelbaum, Susan L.
    Long, Chang-Min
    Gurvich, Irina
    Santella, Regina M.
    Ahsan, Habibul
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2008, 111 (03) : 481 - 487
  • [6] CYP19 (Aromatase) haplotypes and endometrial cancer risk
    Paynter, RA
    Hankinson, SE
    Colditz, GA
    Kraft, P
    Hunter, DJ
    De Vivo, I
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2005, 116 (02) : 267 - 274
  • [7] A rare CYP19 (aromatase) variant may increase the risk of breast cancer
    Kristensen, VN
    Andersen, TI
    Lindblom, A
    Erikstein, B
    Magnus, P
    Borresen-Dale, AL
    [J]. PHARMACOGENETICS, 1998, 8 (01): : 43 - 48
  • [8] A CYP19 (aromatase) polymorphism is associated with increased premenopausal breast cancer risk
    Kathryn E. Talbott
    Marilie D. Gammon
    Muhammad G. Kibriya
    Yu Chen
    Susan L. Teitelbaum
    Chang-Min Long
    Irina Gurvich
    Regina M. Santella
    Habibul Ahsan
    [J]. Breast Cancer Research and Treatment, 2008, 111 : 481 - 487
  • [9] Haplotype-tagging analyses of aromatase (CYP19) and risk of breast cancer.
    Olson, Janet E.
    Ma, Cynthia X.
    Pelleymounter, Linda L.
    Schaid, Daniel J.
    Pankratz, V. Shane
    Vierkant, Robert A.
    Fredericksen, Zachary S.
    Sellers, Thomas A.
    Weinshilboum, Richard M.
    [J]. CANCER RESEARCH, 2006, 66 (08)
  • [10] A haplotype analysis of CYP19 (aromatase) and genetic predisposition to ovarian cancer
    Levine, Douglas A.
    Lee, Catherine S.
    Bogomolniy, Faina
    Boyd, Jeff
    [J]. GYNECOLOGIC ONCOLOGY, 2007, 104 (03) : S22 - S22
12345